2025-04-14
Pfizer just had a big setback in its race for an Ozempic competitor
Pfizer (PFE) announced Monday that it is ending development of its daily weight-loss pill following a liver injury to a patient participating in a trial.
[...]Rating
Innovation
Pricing
Technology
Usability
We have discovered similar tools to what you are looking for. Check out our suggestions for similar AI tools.
2025-02-28
Engadget Podcast: iPhone 16e review and Amazon's AI-powered Alexa+
The keyword for the iPhone 16e seems to be "compromise." In this episode, Devindra chats with Cherlynn about her iPhone 16e review and try to figure out who this phone is actually for. Also, [...]
2025-04-14
Tony Hogben, Immersive Studio Lead at Pfizer Digital Omnichannel Services & Solutions (OSS) – Interview Series
Tony Hogben is the Immersive Studio Lead at Pfizer Digital Omnichannel Services & Solutions (OSS). Pfizer Digital Omnichannel Services & Solutions (OSS) is at the forefront of transforming how [...]
2025-06-09
Pfizer, drug companies make 'no commitments' to White House about lowering drug prices
Cheaper pharmaceuticals won’t be on shelves any time soon, says the CEO of Pfizer. That’s despite an executive order signed last month declaring a war on drug prices, which at one point President [...]
2025-05-30
How Ozempic maker Novo Nordisk fell behind Eli Lilly in the weight loss drug race
Novo Nordisk (NVO) makes Ozempic, the best-known GLP-1 drug out today. And until quite recently, the Danish pharma giant consistently led the pack in new prescriptions, becoming virtually synonymous w [...]
2025-02-13
Formula E will finally debut its fast-charging pit stops this weekend
After announcing initial plans two years ago, Formula E is finally ready to deploy its fast-charging pit stops in an official race. At the Jeddah E-Prix in Saudi Arabia this weekend, the all-electric [...]
2025-03-07
Wegovy's price cut, Amgen's Ozempic competitor, and Big Pharma's tax cut: Pharma news roundup
Novo Nordisk just cut the price of its weight-loss drug, Wegovy, by more than half for patients who pay without insurance. Amgen (AMGN) announced this week that it has begun two late-stage clinical tr [...]